Dr. Tsai will help coordinate the national testing and treatment response in a collaborative effort across federal agencies. One important effort will be the continued expansion of the Test to Treat initiative, a national system of sites where people can receive COVID-19 testing and, if they are positive and treatments are appropriate, immediately obtain a prescription for an oral antiviral medication. Dr. Tsai will be taking a sabbatical to serve in his new role at the White House.
Thomas Tsai, MD, MPH
Director, Clinical Care Redesign, Department of Surgery
Assistant Professor of Surgery, Harvard Medical School
Dr. Tsai’s clinical interests include the surgical and endoscopic management of gastroesophageal reflux disease, bariatric surgery and complex abdominal wall reconstruction. His current research uses Medicare claims and other large national datasets to study the effectiveness and unintended consequences of health policy interventions on the affordability, accessibility and quality of health care in the United States.
In addition to his work as a minimally invasive bariatric surgeon, Dr. Tsai serves as director of Clinical Care Redesign in the Department of Surgery, where he leads a Surgical Care Redesign Lab with a focus on innovating, testing and scaling value-based care models for surgical patients. He is also an associate faculty member of the Center for Surgery and Public Health and Ariadne Labs. Additionally, he is an assistant professor of surgery at Harvard Medical School and assistant professor in the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health.
Dr. Tsai is a graduate of Harvard College, received his medical degree from Stanford University School of Medicine and completed an MPH at the Harvard T.H. Chan School of Public Health. He completed a residency in general surgery at Brigham and Women’s Hospital, followed by a fellowship in minimally invasive bariatric and advanced GI surgery at Massachusetts General Hospital.
